Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NSAID Prodrugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112321424B reveals a novel inorganic base catalyzed route for 2S-(+)-flurbiprofen axetil, offering superior optical purity and yield for reliable pharmaceutical intermediate supply chains.